WebDisclosure WebDisclosure
Basculer en Français
10740 Companies
230344 Keywords
158744 Articles
122336 Press releases
Headlines Articles Press releases Newron Pharmaceuticals S.p.A. Remove
  1. Home
  2. Companies
  3. Newron Pharmaceuticals S.p.A.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 03/17/2023 at 07:00, 3 years 3 months ago

    Newron to present at the 31st European Congress of Psychiatry  

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 03/14/2023 at 07:00, 3 years 4 months ago

    Newron announces 2022 financial results and provides outlook for 2023

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 02/16/2023 at 07:00, 3 years 5 months ago

    Newron reports striking one-year interim efficacy results from its Phase II clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 01/03/2023 at 07:00, 3 years 6 months ago

    Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia

    Logo of Newron Pharmaceuticals S.p.A.
Previous page
1 ... 10 11
Accesswire
  • Published on 07/17/2026 at 01:00, 57 minutes ago

    RJK Explorations Ltd. Announces Closing of Private Placement for Gross Proceeds of $310,000

  • Published on 07/17/2026 at 00:00, 1 hour 57 minutes ago

    LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline

  • Published on 07/16/2026 at 16:21, 9 hours 36 minutes ago

    First Canadian Graphite Completes Phase I Exploration on Zone 13 Discovery and Expands Lands Package

  • Published on 07/16/2026 at 15:30, 10 hours 27 minutes ago

    Caldwell Announces Leadership Appointments for Industrial Practice and Caldwell Analytics

  • Published on 07/16/2026 at 15:30, 10 hours 27 minutes ago

    Resilient Energy Inc. Advances Commercial Rollout; Operations Enter Final Stage Ahead of Revenue Generation

View all ACCESSWIRE
EQS Group
  • Published on 07/16/2026 at 23:10, 2 hours 47 minutes ago

    EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration

  • Published on 07/16/2026 at 21:16, 4 hours 41 minutes ago

    Hertz Energy Advances Its Lake George Antimony-Tungsten Project and Summarizes Lithium Project

  • Published on 07/16/2026 at 20:59, 4 hours 58 minutes ago

    EQS-Adhoc: SMA publishes preliminary results for the second quarter of 2026 and raises full-year 2026 guidance

  • Published on 07/16/2026 at 20:39, 5 hours 18 minutes ago

    AUTODOC successfully optimises capital structure

  • Published on 07/16/2026 at 20:05, 5 hours 51 minutes ago

    Turkiye Garanti Bankasi A.S.: Announcement regarding Moody's rating affirmation

View all EQS
Les Echos
  • Published on 07/16/2026 at 20:27, 5 hours 30 minutes ago

    BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE

  • Published on 07/16/2026 at 18:08, 7 hours 49 minutes ago

    Aéroports de Paris S.A - June and half-year 2026 traffic figures

  • Published on 07/16/2026 at 18:08, 7 hours 49 minutes ago

    Aéroports de Paris S.A - Trafic du mois de juin et du 1er semestre 2026

  • Published on 07/16/2026 at 18:00, 7 hours 57 minutes ago

    i2S Chiffre d'affaires S1 2026

  • Published on 07/16/2026 at 17:45, 8 hours 12 minutes ago

    H1 2026 revenue: €6.1m (+14%)

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy